|
|
|
|
     |
|
|
||
|
|
PUBLICATIONS
2005 - Present Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009 Oct; 374(9697):1252-61. 
Clarke H, Pereira S, Kennedy D, Gilron I, Katz J, Gollish J, Kay J. Gabapentin decreases morphine consumption and improves functional recovery following total knee arthroplasty. Pain Res Manag. 2009 May-Jun;14(3):217-22.
Gilron I, Orr E, Tu D, Mercer CD, Bond D. A randomized, double-blind, controlled trial of perioperative administration of gabapentin, meloxicam and their combination for spontaneous and movement-evoked pain after ambulatory laparoscopic cholecystectomy. Anesth Analg. 2009 Feb;108(2):623-30.
Erb J, Orr E, Mercer CD, Gilron I. Interactions between pulmonary performance and movement-evoked pain in the immediate postsurgical period: implications for perioperative research and treatment. Reg Anesth Pain Med. 2008 Jul-Aug; 33(4):312-9.
Gilron I Optimizing neuropathic pain pharmacotherapy: add on or switch over? Nat Clin Pract Neurol. 2008 Nov;12(8):990-9.
Greenspan JD, Coghill RC, Gilron I, Sarlani E, Veldhuijzen DS, Lenz FA. Quantitative somatic sensory testing and functional imaging of the response to painful stimuli before and after cingulotomy for obsessive-compulsive disorder (OCD). Eur J Pain 2008 Nov;12(8):990-9.
Gilron I. Analgesia controlled with patience: Towards a better understanding of analgesic self-administration behaviour. Canadian Journal of Anesthesia Can J Anaesth. 2008 Feb; 55(2):75-81.
Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: Current evidence and future directions. Canadian Current Opinion in Anaesthesiology 2007; 20:456-472.
Boscariol R, Gilron I, Orr E. Chronobiological characteristics of postoperative pain: diurnal variation of both static and dynamic pain and effects of analgesic therapy. Canadian Journal of Anesthesia 2007; 54:696-704.
Moulin DE, Clark AJ, Gilron I, et al. Pharmacologic Management Of Chronic Neuropathic Pain - Consensus Statement And Guidelines From The Canadian Pain Society. Pain Research Management 2007; 12:13-21.
Gilron I, Coderre TJ. Emerging drugs in neuropathic pain. Expert Opinion in Emerging Drugs 2007; 12:113-26.
Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. Canadian Medical Association Journal, 2006; 102(5):1473-9.
Gilron I, Flatters SJ. Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence. Pain Research Management 2006; 11 Suppl A:16A-29A. Gilron I. Review article: the role of anticonvulsant drugs in postoperative pain management: a bench-to-bedside perspective. Canadian Journal of Anesthesia 2006; 53:562-71.
Deshpande MA, Holden RR, Gilron I. The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction? Anesth Analg. 2006; 102:1473-9.
Odrcich M, Bailey JM, Cahill CM, Gilron I. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy. Pain 2006; 120:207-12.
Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: current evidence and future directions Expert Review in Neurotherapeutics 2005; 5:823-30.
Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine 2005; 352:1324-34.
Gilron I, Orr E, Tu D, O'Neill JP, Zamora JE, Bell AC. A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy. Pain 2005 Jan; 113(1-2):191-200.
2000-2004 
Gilron I. Corticosteroids in postoperative pain management: Future research directions for a multifaceted therapy (Editorial). Acta Anaesthesiologica Scandanavica 2004;48:1221-2. Gilron I. Exploring novel drug targets in pain management: New opportunities in bench-to-bedside research. Queen's Health Sciences Journal 2004; 7:28-32. Hansen C, Gilron I, Hong M. Effects of intrathecal gabapentin on spinal morphine tolerance in the rat tail-flick and paw pressure tests. Anesthesia & Analgesia 2004 Oct; 99(4):1180-4.
Gilron I. Gabapentin (Editorial). CNS Drugs 2003; 17:983-4.
Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors in postoperative pain management: Current evidence and future directions. Anesthesiology 2003; 99:1198-208. Gilron I, Biederman J, Jhamandas K, Hong M. Gabapentin blocks, and reverses, antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests. Anesthesiology 2003; 98:1288-92. Gilron I. Gabapentin: the first preemptive anti-hyperalgesic for opioid withdrawal hyperalgesia? In Reply (letter). Anesthesiology 2003; 98:1520-2. Gilron I, Bailey JM. Trends in opioid use for chronic neuropathic pain: A survey of patients pursuing enrollment in clinical trials. Canadian Journal of Anesthesia, 2003; 50:42-47.
Gilron I, Tod D, Goldstein DH, Parlow JL, Orr E. The relationship between evoked versus spontaneous pain and peak expiratory flow after abdominal hysterectomy. Anesthesia & Analgesia, 2002; 95(6):1702-7.
Gilron I. Is gabapentin a "broad spectrum" analgesic? (Editorial). Anesthesiology 2002; 97:537-9.
Gilron I, Bailey JM, Weaver DF, Houlden RL. Patients' attitudes and prior treatments in neuropathic pain: A pilot study. Pain Research & Management 2002; 7(4):199-203.
Sang CN, Booher SL, Gilron I, Parada S, Max MB. Dextromethorphan and Memantine in Painful Diabetic Neuropathy and Postherpetic Neuralgia: Efficacy and Dose-Response Trials. Anesthesiology 2002; 96:1053-61.
Gilron I. Therapeutic potential of the AMPA/kainate receptor antagonist LY293558 in the management of pain and other central nervous system disorders. Current Opinions in Investigational Drugs 2001; 2:1273-1278.
Max MB, Gilron I. Antidepressants, muscle relaxants, and NMDA receptor antagonists in: Bonica's Management of Pain, 3rd Edition, JD Loeser, D Turk, CR Chapman, S Butler, Editors Williams & Wilkins, 2001. Coghill RC, Gilron I, Iadarola MJ. Hemispheric lateralization of somatosensory processing. Journal of Neurophysiology 2001; 85:2602.
Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in Trigeminal Neuralgia: A Randomized, Placebo-Controlled Multiple Crossover Pilot Study. Clinical Neuropharmacology 2001; 24:109-12.
Gilron I, Booher SL, Rowan JS, Smoller B, Max MB. A randomized controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology 2000; 55:964-71.
Gilron I, Max MB, Lee G, Booher SL, Sang CN, Chappell AS, Dionne RA. Effects of the AMPA/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Clinical Pharmacology and Therapeutics 2000; 68:320-7.
Gilron I. Neural blockade in the evaluation and management of chronic pain: An overview. Pain Research & Management 2000; 5:93-100. 1987-1999
Gilron I, Quirion R, Coderre TJ. Pre- versus post-formalin effects of Ketamine or large-dose Alfentanil in the rat: Discordance between pain behavior and spinal fos-like immunoreactivity (FLI). Anesthesia and Analgesia 1999; 89:128-35.
Max MB, Gilron I. Sympathetically-maintained pain: Has the emperor no clothes? (Editorial). Neurology 1999; 52:905-7.
Gilron I, Quirion R, Coderre TJ. Pre- versus post-injury effects of intravenous gabaergic anesthetics on formalin-induced fos immunoreactivity in the rat spinal cord.
Gilron I, Plourde G, Marcantoni W, Varin F. The 40-Hz auditory steady-state response and EEG spectral edge frequency during sufentanil anaesthesia. Canadian Journal of Anaesthesia 1998; 45:115.
Gilron I, Coderre TJ. Novel targets of pain modulation in anaesthesia: Preventing painful memories (editorial). Canadian Journal of Anaesthesia. 1997; 44:457-462.
Backman SB, Gilron I, Robbins GR. Protamine and its cardiovascular effects - Reply (letter). Canadian Journal of Anaesthesia 1997; 44:1323. Backman S, Gilron I, Robbins GR. Protamine-induced bradycardia in a previous heart transplant recipient. Canadian Journal of Anaesthesia 1997; 44:520-524.
Gilron I, Coderre TJ. Is Pentobarbital analgesic in the rat formalin test? In Reply:(letter) Anesthesiology 1997; 86:266-267. Gilron I, Coderre TJ. Preemptive analgesic effects of steroid anesthesia with alphaxalone in the rat formalin test: Evidence for differential gamma-aminobutyric acidA receptor modulation in persistent nociception. Anesthesiology 1996; 84:572-579.
Gilron I, Solomon P, Plourde G. Unintentional intraoperative awareness during high dose sufentanil anesthesia for cardiac surgery. Canadian Journal of Anaesthesia 1996; 43:295-8.
Gilron I, Magder S. Case Report: Monitoring complication due to a pulsatile femoral vein from tricuspid regurgitation. Canadian Journal of Anaesthesia 1995; 42:141-3.
Gilron I. The introduction of new drugs into anaesthetic practice: A perspective in pharmaceutical development and regulation. Canadian Journal of Anaesthesia 1995; 42:516-22.
Gilron I, Scott WAC, Slinger P, Wilson JAS. Case report: contralateral lung soiling following laser resection of a bronchial tumour. Journal of Cardiothoracic and Vascular Anesthesia 1994; 8:567-569.
Gilron I. Anaesthesia equipment safety in Canada: the role of government regulation. Canadian Journal of Anaesthesia 1993; 40:987-92.
Wiesel S., Gilron I. Portex epidural catheters (letter). Canadian Journal of Anaesthesia 1993; 40:397-8.
Gilron I. The Emergency Drug Release Program: Regulatory aspects of new drug access in Canada. Canadian Medical Association Journal 1993; 148:1151-3.
Baer HH, Gilron I. Preparation of some carbohydrate pyrazolines by cycloaddition of diazomethane to nitroalkenic sugars. Carbohydrate Research 1987; 164:486-92.
| |
|
|
||
|
|
|
Copyright: Department of Anesthesiology & Perioperative Medicine, Queen's University. All rights reserved | Disclaimer. Website developed and maintained by WhiteSpaceNorth.com. |
